A Phase I Safety, Pharmacodynamic, Anti-Tumor Activity, and Pharmacokinetic Study of PXD101 Alone and in Combination With 5-Fluorouracil in Patients With Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 08 Jul 2015
At a glance
- Drugs Belinostat (Primary) ; Fluorouracil
- Indications Adenocarcinoma; Colorectal cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Sponsors TopoTarget
- 07 Jun 2017 Biomarkers information updated
- 08 Apr 2009 Actual patient number (35) added as reported by ClinicalTrials.gov.
- 08 Apr 2009 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.